University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments Subchapter
Status: Red Human menopausal gonadotrophins injection (Menotrophin) 6.5
Status: Green Human papillomavirus vaccine - Cervarix

Use Gardisil first line

10.4
Status: Green Human papillomavirus vaccine - Gardisil

First Line following DOH advice from 2012, Supported with PGD

14.4
Status: Red Hyaluronic acid solution (Deep Blue®)

For submucosal lifting for endoscopic resection

18.1
Status: Red Hydralazine injection

Hospital only.

2.5
Status: Green Hydralazine tablets

Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes

2.5
Status: Green Hydrocortisone 0.1% lipocream

Potent

13.4
Status: Green Hydrocortisone 0.5% cream

Mild potency

13.4
Status: Green Hydrocortisone 0.5% ointment

Mild potency

13.4
Status: Green Hydrocortisone 1% and Oxytetracycline 3% (Terra-Cortril®) ointment

Potency: mild

13.4

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top